Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Gongwin Biopharm Holdings Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 1.99.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gongwin Biopharm Holdings Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.22.
Gongwin Biopharm Holdings Co (ROCO:6617) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Gongwin Biopharm Holdings Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gongwin Biopharm Holdings Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Gongwin Biopharm Holdings Co Days Inventory Related Terms
Gongwin Biopharm Holdings Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6617 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Gongwin Biopharm Holdings Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gongwin Biopharm Holdings Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gongwin Biopharm Holdings Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Gongwin Biopharm Holdings Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gongwin Biopharm Holdings Co (ROCO:6617) has a Days Inventory of 45.90 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gongwin Biopharm Holdings Co and its competitors. This is 78% below median its historical median of 204.17. Over the past decade, Gongwin Biopharm Holdings Co's Days Inventory has ranged from 78.83 to 1,000.19. According to the industry distribution chart, Gongwin Biopharm Holdings Co ranks #170 out of 638 companies in the Biotechnology industry, placing it in the top 26.6%.
Is Gongwin Biopharm Holdings Co's Days Inventory too high?
Gongwin Biopharm Holdings Co's current Days Inventory of 45.90 is 78% below median its 10-year median of 204.17. Over the past 10 years, this metric has ranged from a low of 78.83 to a high of 1,000.19. The Biotechnology industry median Days Inventory is 183.20. Gongwin Biopharm Holdings Co's value of 45.90 is 74.9% below this industry median. Based on the distribution chart, Gongwin Biopharm Holdings Co ranks #170 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Gongwin Biopharm Holdings Co has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gongwin Biopharm Holdings Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gongwin Biopharm Holdings Co ranks #170 out of 638 companies for Days Inventory. This puts Gongwin Biopharm Holdings Co in the upper half of its industry. The industry median Days Inventory is 183.20. Gongwin Biopharm Holdings Co's value of 45.90 is 74.9% below this benchmark. Historically, Gongwin Biopharm Holdings Co's own Days Inventory has ranged from 78.83 to 1,000.19 over the past decade. While the company's 10-year median is 204.17 vs. the industry median of 183.20, Gongwin Biopharm Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gongwin Biopharm Holdings Co's current Days Inventory of 45.90 is 74.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gongwin Biopharm Holdings Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gongwin Biopharm Holdings Co's current Days Inventory is 45.90, which is 78% below median its own 10-year median of 204.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gongwin Biopharm Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Gongwin Biopharm Holdings Co (ROCO:6617) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$151.81, compared to a current price of NT$98.80 — trading 34.9% below its estimated fair value. The current Days Inventory is 45.90, which is 78% below median its 10-year median of 204.17 and 74.9% below the Biotechnology industry median of 183.20. Gongwin Biopharm Holdings Co's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Gongwin Biopharm Holdings Co (ROCO:6617), the current Days Inventory is 45.90 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gongwin Biopharm Holdings Co (ROCO:6617) Overvalued in 2026?
Based on GuruFocus' analysis, Gongwin Biopharm Holdings Co stock appears to be undervalued.
The current stock price of NT$98.80 is trading 34.9% below its estimated GF Value™ of NT$151.81.
GuruFocus considers Gongwin Biopharm Holdings Co to be Significantly Undervalued.
Key valuation signals for ROCO:6617:
Days Inventory: 45.90 (78% below median its 10-year median of 204.17)
GF Value™: NT$151.81 vs. price of NT$98.80 (34.9% below fair value)
Industry Position: 74.9% below the Biotechnology median (#170 of 638)
No single metric tells the full story. See the ROCO:6617 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gongwin Biopharm Holdings Co Ltd is a Taiwan-based biopharmaceutical company focused on developing novel anti-cancer drugs. The company develops products related to central lung serious tracheal obstruction, primary liver cancer, malignant pleural effusion, and tracheal adenoid cystic carcinoma. The Group includes pharmaceutical research and development, drug testing, pharmaceutical technology consulting, biotechnology services, technology transfer, and the sale of new drugs.
71GF Score
Get the complete analysis for ROCO:6617
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6617 has been successfully added to your 
